HLA EXPRESSION IN PREINVASIVE CERVICAL NEOPLASIA IN RELATION TO HUMAN PAPILLOMA-VIRUS INFECTION

被引:41
作者
GLEW, SS
CONNOR, ME
SNIJDERS, PJF
STANBRIDGE, CM
BUCKLEY, CH
WALBOOMERS, JMM
MEIJER, CJLM
STERN, PL
机构
[1] CHRISTIE HOSP NHS TRUST, PATERSON INST CANC RES, CANC RES CAMPAIGN, DEPT IMMUNOL, MANCHESTER M20 9BX, LANCS, ENGLAND
[2] NO GEN HOSP, DEPT OBSTET & GYNAECOL, SHEFFIELD, S YORKSHIRE, ENGLAND
[3] FREE UNIV AMSTERDAM, ACAD ZIEKENHUIS, INST PATHOL, 1081 HV AMSTERDAM, NETHERLANDS
[4] ST MARYS HOSP, DEPT PATHOL, MANCHESTER, LANCS, ENGLAND
关键词
HLA; CERVICAL INTRAEPITHELIAL NEOPLASIA; HUMAN PAPILLOMA VIRUS; MHC CLASS II;
D O I
10.1016/0959-8049(93)90453-M
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A significant proportion of cervical carcinomas show loss of major histocompatibility complex human leucocyte antigen (HLA) class I expression while upregulating HLA class II expression. These changes may have direct consequences for immune surveillance of the human papilloma virus (HPV) infection which is strongly associated with cervical malignancy. A relationship between changes in HLA expression and HPV infection may be evident in the evolution of premalignant disease. This immunohistological study of 104 colposcopic biopsies establishes that HLA class II expression occurs in a significant proportion of squamous epithelia showing histological evidence of war virus infection and cervical intraepithelial neoplasia (CIN) I to III. In comparison, alteration of HLA class I expression in cervical premalignant lesions is rare. There is no correlation between the detection of high risk HPV DNA (types 16, 18, 31 and 33) by polymerase chain reaction (PCR) and the MHC class II phenotype of the lesion. This suggests that altered HLA class II expression is neither a consequence nor a prerequisite for HPV infection.
引用
收藏
页码:1963 / 1970
页数:8
相关论文
共 31 条
  • [1] CURRENT VIEWS ON CERVICAL INTRAEPITHELIAL NEOPLASIA
    ANDERSON, MC
    BROWN, CL
    BUCKLEY, CH
    FOX, H
    JENKINS, D
    LOWE, DG
    MANNERS, BTB
    MELCHER, DH
    ROBERTSON, AJ
    WELLS, M
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1991, 44 (12) : 969 - 978
  • [2] ANTIGEN PRESENTATION BY KERATINOCYTES INDUCES TOLERANCE IN HUMAN T-CELLS
    BAL, V
    MCINDOE, A
    DENTON, G
    HUDSON, D
    LOMBARDI, G
    LAMB, J
    LECHLER, R
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (09) : 1893 - 1897
  • [3] BRINTON LA, 1987, J NATL CANCER I, V79, P23
  • [4] BUCKLEY CH, 1989, RECENT ADV HISTOPATH, V14, P63
  • [5] BURGHARDT E, 1983, OBSTET GYNECOL, V62, P117
  • [6] LOSS OF MHC CLASS-I EXPRESSION IN CERVICAL CARCINOMAS
    CONNOR, ME
    STERN, PL
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1990, 46 (06) : 1029 - 1034
  • [7] EVALUATION OF MULTIPLE BIOLOGIC PARAMETERS IN CERVICAL-CARCINOMA - HIGH MACROPHAGE INFILTRATION IN HPV-ASSOCIATED TUMORS
    CONNOR, ME
    DAVIDSON, SE
    STERN, PL
    ARRAND, JR
    WEST, CML
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1993, 3 (02) : 103 - 109
  • [8] COPPLESON M, 1967, PRECLINICAL CARCINOM, P321
  • [9] HLA-DR EXPRESSION IS ASSOCIATED WITH EXCELLENT PROGNOSIS IN SQUAMOUS-CELL CARCINOMA OF THE LARYNX
    ESTEBAN, F
    RUIZCABELLO, F
    CONCHA, A
    PEREZAYALA, M
    SANCHEZROZAS, JA
    GARRIDO, F
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 1990, 8 (04) : 319 - 328
  • [10] EXPRESSION OF MHC PRODUCTS AND LEUKOCYTE DIFFERENTIATION ANTIGENS IN GYNECOLOGICAL NEOPLASMS - AN IMMUNOHISTOLOGICAL ANALYSIS OF THE TUMOR-CELLS AND INFILTRATING LEUKOCYTES
    FERGUSON, A
    MOORE, M
    FOX, H
    [J]. BRITISH JOURNAL OF CANCER, 1985, 52 (04) : 551 - 563